|
| |
Leukemia LymphomaDownload PDF containing detailed information.
Recent Publications on Leukemia Lymphoma: |  |
Spectrum of BCR-ABL kinase domain mutations in patients with chronic myeloid leukemia from India with suspected resistance to imatinib-mutations are rare and have different distributions.
Chromosomal abnormalities, immunoglobulin heavy chain variable-region... | 21st November, 2009
| Department of Haematology.
| Leuk Lymphoma. 2009 Nov 19.
|
Prognostic immunophenotypic biomarker studies in diffuse large B cell lymphoma with special emphasis on rational determination of cut-off scores.
A number of biomarkers, particularly proteins that contribute to prognosis... | 21st November, 2009
| Institute of Pathology, University of Basel, Basel, Switzerland.
| Leuk Lymphoma. 2009 Nov 19.
|
Tricky B-usiness: hematogones in aplastic anemia.
A number of biomarkers, particularly proteins that contribute to prognosis... | 21st November, 2009
| Department of Pediatric Hematology and Oncology, University of Freiburg,
| Leuk Lymphoma. 2009 Nov 19.
|
Vincristine but not imatinib could suppress mesenchymal niche's support to lymphoid leukemic cells.
Bone marrow mesenchymal stromal cells (MSCs) can rescue acute... | 21st November, 2009
| Department of Paediatrics & Adolescent Medicine.
| Leuk Lymphoma. 2009 Nov 19.
|
Phosphorylation regulates human T-cell leukemia virus type 1 Rex function.
ABSTRACT: BACKGROUND: Human T-cell leukemia virus type 1 (HTLV-1) is a... | 19th November, 2009
|
| Retrovirology. 2009 Nov 17;6(1):105.
DOI Direct Link |
→View more research publications. |
Press Releases About Leukemia Lymphoma:
|
 |
| Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and Non-Clinical Data at 51st American Society of Hematology Annual Meeting |
24th November, 2009 |
Ambit Biosciences Corporation |
SAN DIEGO, Nov. 24 /PRNewswire/ -- Ambit Biosciences Corporation announced today that there will be multiple presentations evaluating AC220, a novel second generation FLT3 inhibitor, in AML at the
|
| Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) |
19th November, 2009 |
AEGERA THERAPEUTICS INC. |
MONTREAL, Nov. 19 /PRNewswire/ - Aegera Therapeutics Inc. announced today the dosing of the first patient in a randomized Phase 2B study of AEG35156, a targeted antisense therapeutic in mid-stage
|
| These Patients Need Your Help This Thanksgiving |
17th November, 2009 |
New York Blood Center |
NEW YORK, Nov. 17 /PRNewswire-USNewswire/ -- As we approach Thanksgiving, "Black Friday" and the holiday season, New York Blood Center (NYBC) calls upon the community to please remember the
|
| EntreMed's ENMD-2076 Active in Solid and Hematological Cancers |
16th November, 2009 |
EntreMed, Inc. |
ROCKVILLE, Md., Nov. 16 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer today announced the
|
| Pharmacyclics Announces Poster Presentations and Clinical Update at the 51st Annual Meeting of the American Society of Hematology |
12th November, 2009 |
Pharmacyclics, Inc. |
SUNNYVALE, Calif., Nov. 12 /PRNewswire-FirstCall/ -- Pharmacyclics, Inc. (Nasdaq: PCYC) today announced that posters related to PCI-24781 and PCI-32765 have been selected for presentation at the 51st
|
BioPortfolio Ltd. offers e-mail and postal lists for Leukemia Lymphoma scientists - we have details of around 2335 individuals working on Leukemia Lymphoma .
This page has been viewed 311 times
Recent Search Terms used to find this page: fda approval sleeping beauty t cell | Leukemia and Lymphoma Oct 2009 | Leukemia Lymphoma Cancer | Phase II Study of KW-0761 in Subjects With CCR4-Positive Adult T-Cell Leukemia-Lymphoma | where is lymphoma unit duke | Leuk Lymphoma. | mantle cell leukemia | mantle cell leukemia | mantle cell leukemia | .
Browse BioPortfolio's InDepth service - alphabetically:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or by Most Publications, recently searched for, or
most viewed.
Search for Leukemia Lymphoma across BioPortfolio, or for Leukemia Lymphoma Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
Thumbshots from Thumbshots.org
|
